Search filters

List of works by Anne Paulien Drenth

Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

scientific article published in Nature Communications

Exogenous ERα Expression in the Mammary Epithelium Decreases Over Time and Does Not Contribute to p53-Deficient Mammary Tumor Formation in Mice

scientific article published on 15 November 2019

In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer

scientific article published on 13 January 2020

Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma

scientific article published on 26 June 2017

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

scientific article published on 31 July 2019

MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

scientific article published in 2022

Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland

scientific article published on June 2016

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

correction of a scholarly article

Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin

scientific article published on 23 August 2019

Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer.

scientific article published on 22 June 2015

TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development

scientific article published on 26 December 2019

Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547

scientific article published on 16 August 2018

Truncated ASPP2 Drives Initiation and Progression of Invasive Lobular Carcinoma via Distinct Mechanisms

scientific article published on 14 February 2020

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

scientific article published in August 2022

Paulina is supported by:

About Paulina

Help